A resource for intelligent investors. Like you.

With more Fed rate cuts on the horizon, conventional investing wisdom says that cyclical stocks (e.g, automotive, airlines and consumer goods) will benefit the most. But Managing Director Dave Gilreath says that other sectors may actually fare better. Read his latest article in Financial Advisor to learn more.

Great expectations can lead to great disappointment, especially with the stock market. But even though there weren’t as many rate cuts in 2024 as expected, Managing Director Dave Gilreath says that’s no reason to sell your stocks. Read why in his latest Medical Economics article.

Over the past 12 months, the utility sector has been shining brightly, and Managing Director Dave Gilreath explores how the sector may continue to perform in his latest article for Investing.com.

Post-Fed rate cuts, everyone is trying to determine which stock sectors may particularly perform well. But while cyclical sectors seem to be the fan favorites, Managing Director Dave Gilreath suggests that other, less obvious, parts of the market may fare even better. Read more in his latest Financial Advisor article.

Worried about how the presidential election results will affect the market? You’re not alone. But, in his latest Medical Economics article, Managing Director Dave Gilreath says there’s no need to be anxious—the election may not actually make much difference.

The Fed finally cut fund rates and it’s been a hot topic. This means lower loans for pretty much everyone, but real estate investment trusts (REITs) are specifically well-poised to potentially benefit. Read why in Research Analyst & Portfolio Manager Tom Kaiser‘s latest article for Medical Economics.